SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-22-055295
Filing Date
2022-05-03
Accepted
2022-05-03 16:35:19
Documents
4
Effectiveness Date
2022-05-03

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2213197d1_s8.htm S-8 41880
2 EXHIBIT 5.1 tm2213197d1_ex5-1.htm EX-5.1 6418
3 EXHIBIT 23.1 tm2213197d1_ex23-1.htm EX-23.1 3088
4 EX-FILING FEES tm2213197d1_ex-filingfees.htm EX-FILING FEES 11854
  Complete submission text file 0001104659-22-055295.txt   64373
Mailing Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105
Business Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105 (781) 788-8869
KIORA PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-264640 | Film No.: 22887591
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences